Our data analysis demonstrated that both OS and PFS for patients with serous ovarian carcinoma expressing high CX3CR1 is significantly shorter than that for patients with low CX3CR1 (Fig. 1a). The gene discussed is CX3CR1; the disease is ovarian serous carcinoma.